APA (7th ed.) Citation

SV, R., KN, H., W, M., NJ, H., JT, K., X, H., . . . LH, C. (2015). Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial. The Lancet. Neurology, 14(2), 153. https://doi.org/10.1016/S1474-4422(14)70318-7

Chicago Style (17th ed.) Citation

SV, Raman, et al. "Eplerenone for Early Cardiomyopathy in Duchenne Muscular Dystrophy: A Randomised, Double-blind, Placebo-controlled Trial." The Lancet. Neurology 14, no. 2 (2015): 153. https://doi.org/10.1016/S1474-4422(14)70318-7.

MLA (9th ed.) Citation

SV, Raman, et al. "Eplerenone for Early Cardiomyopathy in Duchenne Muscular Dystrophy: A Randomised, Double-blind, Placebo-controlled Trial." The Lancet. Neurology, vol. 14, no. 2, 2015, p. 153, https://doi.org/10.1016/S1474-4422(14)70318-7.